These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 12971387)

  • 41. Inhibition of SRC family kinases and receptor tyrosine kinases by dasatinib: possible combinations in solid tumors.
    Montero JC; Seoane S; Ocaña A; Pandiella A
    Clin Cancer Res; 2011 Sep; 17(17):5546-52. PubMed ID: 21670084
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cyclin-dependent kinase inhibitors: a survey of recent patent literature.
    Galons H; Oumata N; Meijer L
    Expert Opin Ther Pat; 2010 Mar; 20(3):377-404. PubMed ID: 20180621
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [A novel small molecule cyclin-dependent kinase inhibitor flavopiridol in cancer therapy].
    Song Y; Shen J
    Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(12):862-4. PubMed ID: 15949412
    [No Abstract]   [Full Text] [Related]  

  • 44. Mechanism of inhibition of eosinophil activation by transforming growth factor-beta. Inhibition of Lyn, MAP, Jak2 kinases and STAT1 nuclear factor.
    Pazdrak K; Justement L; Alam R
    J Immunol; 1995 Nov; 155(9):4454-8. PubMed ID: 7594607
    [TBL] [Abstract][Full Text] [Related]  

  • 45. American Association for Cancer Research 98th Annual Meeting. Anticancer agents - Part II.
    Filson S
    IDrugs; 2007 Jun; 10(6):359-61. PubMed ID: 17641994
    [No Abstract]   [Full Text] [Related]  

  • 46. CDK inhibitors in cancer therapy: what is next?
    Malumbres M; Pevarello P; Barbacid M; Bischoff JR
    Trends Pharmacol Sci; 2008 Jan; 29(1):16-21. PubMed ID: 18054800
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interleukin-6 induces transcriptional activation of vascular endothelial growth factor (VEGF) in astrocytes in vivo and regulates VEGF promoter activity in glioblastoma cells via direct interaction between STAT3 and Sp1.
    Loeffler S; Fayard B; Weis J; Weissenberger J
    Int J Cancer; 2005 Jun; 115(2):202-13. PubMed ID: 15688401
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Rituximab inactivates signal transducer and activation of transcription 3 (STAT3) activity in B-non-Hodgkin's lymphoma through inhibition of the interleukin 10 autocrine/paracrine loop and results in down-regulation of Bcl-2 and sensitization to cytotoxic drugs.
    Alas S; Bonavida B
    Cancer Res; 2001 Jul; 61(13):5137-44. PubMed ID: 11431352
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Iressa (ZD 1839) inhibits phosphorylation of three different downstream signal transducers in head and neck cancer (SCCHN).
    Hambek M; Baghi M; Baumaun H; Strebhardt K; Adunka O; Gstöttner W; Knecht R
    Anticancer Res; 2005; 25(3B):1871-5. PubMed ID: 16158919
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Association of Stat3-dependent transcriptional activation of p19INK4D with IL-6-induced growth arrest.
    Narimatsu M; Nakajima K; Ichiba M; Hirano T
    Biochem Biophys Res Commun; 1997 Sep; 238(3):764-8. PubMed ID: 9325164
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibition of constitutively active Stat3 suppresses proliferation and induces apoptosis in glioblastoma multiforme cells.
    Rahaman SO; Harbor PC; Chernova O; Barnett GH; Vogelbaum MA; Haque SJ
    Oncogene; 2002 Dec; 21(55):8404-13. PubMed ID: 12466961
    [TBL] [Abstract][Full Text] [Related]  

  • 52. AACR-NCI-EORTC--19th symposium. Molecular Targets and Cancer Therapeutics--Part 3.
    Collins T
    IDrugs; 2007 Dec; 10(12):840-3. PubMed ID: 18041675
    [No Abstract]   [Full Text] [Related]  

  • 53. Carnosol induces apoptosis through generation of ROS and inactivation of STAT3 signaling in human colon cancer HCT116 cells.
    Park KW; Kundu J; Chae IG; Kim DH; Yu MH; Kundu JK; Chun KS
    Int J Oncol; 2014 Apr; 44(4):1309-15. PubMed ID: 24481553
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A Ras homologue member I directly inhibits signal transducers and activators of transcription 3 translocation and activity in human breast and ovarian cancer cells.
    Nishimoto A; Yu Y; Lu Z; Mao X; Ren Z; Watowich SS; Mills GB; Liao WS; Chen X; Bast RC; Luo RZ
    Cancer Res; 2005 Aug; 65(15):6701-10. PubMed ID: 16061651
    [TBL] [Abstract][Full Text] [Related]  

  • 55. New approaches and targets in advanced colorectal cancer.
    Macarulla T; Capdevila J; Perez-Garcia J; Ramos FJ; Elez ME; Markman B; Ruiz-Echarri M; Tabernero J
    Eur J Cancer; 2009 Sep; 45 Suppl 1():79-88. PubMed ID: 19775607
    [No Abstract]   [Full Text] [Related]  

  • 56. [Constitutive activation of MAP kinase pathway and STAT pathway in AML].
    Towatari M; Iida H
    Rinsho Ketsueki; 1998 Feb; 39(2):86-8. PubMed ID: 9545805
    [No Abstract]   [Full Text] [Related]  

  • 57. Antiangiogenic therapy: targeting vascular endothelial growth factor and its receptors.
    Tandle A; Libutti SK
    Clin Adv Hematol Oncol; 2003 Jan; 1(1):41-8. PubMed ID: 16227959
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Interleukin-6-resistant melanoma cells exhibit reduced activation of STAT3 and lack of inhibition of cyclin E-associated kinase activity.
    Böhm M; Schulte U; Funk JO; Raghunath M; Behrmann I; Kortylewski M; Heinrich PC; Kues T; Luger TA; Schwarz T
    J Invest Dermatol; 2001 Jul; 117(1):132-40. PubMed ID: 11442760
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Role of STATs as downstream signal transducers in Src family kinase-mediated tumorigenesis.
    Silva CM
    Oncogene; 2004 Oct; 23(48):8017-23. PubMed ID: 15489919
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Anticancer therapeutics: "Addictive" targets, multi-targeted drugs, new drug combinations.
    Broxterman HJ; Georgopapadakou NH
    Drug Resist Updat; 2005 Aug; 8(4):183-97. PubMed ID: 16154800
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.